INVESTBOARDLog in
Healthcare · Health Information Services · SE

RaySearch Laboratories AB (publ) RAY-B

kr176.70 · close of Nov 6, 2026
AI score · High quality · analysis Jan 21, 2026
8.5 of 10

Management and Business model hold this up; Risk is the soft spot.

Moat8.0
Management9.0
Valuation8.0
Risk · 10 = lowest8.0
Business model9.0
Optionality9.0
Fair value
AI fair value
—
Base case
—
the single most likely path
Analyst consensus
—
12-month target
Price
kr176.70
The business

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

Last report Nov 3, 2026 · next Feb 10, 2027

Write why this business works, set your own fair value, and let the briefing speak only when a rule you wrote is crossed.

Start the thirty days · no card
General investment analysis · not personalized advice · the figures carry their dates